Patents by Inventor Wenhui Lin

Wenhui Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11095697
    Abstract: The present disclosure discloses an Ethernet-based cascading conference phone device, which includes a master conference phone and a slave conference phone. The master conference phone receives at least one network data packet through an Ethernet, obtains a real-time stream signal according to the at least one network data packet, plays the real-time stream signal after a delay, sends the real-time stream signal to the slave conference phone, periodically sends at least one synchronized broadcast packet to the slave conference phone.
    Type: Grant
    Filed: October 9, 2019
    Date of Patent: August 17, 2021
    Assignee: YEALINK (XIAMEN) NETWORK TECHNOLOGY CO., LTD.
    Inventor: Wenhui Lin
  • Patent number: 11002432
    Abstract: A lighting apparatus includes a light source module, a light passing cover, a base housing, a first end module and a second end module. The light source module includes a plurality of LED modules. These LED modules may have different types. Each type has a different optical parameter, like color temperature, color, light intensity, color rendering index. The light passing cover allows a light of the light source module to pass through. The base housing is connected to the light passing cover forming a container space. The base housing has an elongated shape. The first end module and the second end module are attached at two opposite ends of the base housing for sealing the container space. The first end module is selectively connected to another second end module of another lighting apparatus for routing electricity and a control signal.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: May 11, 2021
    Assignee: XIAMEN ECO LIGHTING CO. LTD.
    Inventors: Chunteng Chen, Lei Zhang, Wenhui Lin
  • Publication number: 20210080088
    Abstract: A lighting apparatus includes a light source module, a light passing cover, a base housing, a first end module and a second end module. The light source module includes a plurality of LED modules. These LED modules may have different types. Each type has a different optical parameter, like color temperature, color, light intensity, color rendering index. The light passing cover allows a light of the light source module to pass through. The base housing is connected to the light passing cover forming a container space. The base housing has an elongated shape. The first end module and the second end module are attached at two opposite ends of the base housing for sealing the container space. The first end module is selectively connected to another second end module of another lighting apparatus for routing electricity and a control signal.
    Type: Application
    Filed: May 21, 2020
    Publication date: March 18, 2021
    Inventors: Chunteng Chen, Lei Zhang, Wenhui Lin
  • Publication number: 20200145467
    Abstract: The present disclosure discloses an Ethernet-based cascading conference phone device, which includes a master conference phone and a slave conference phone. The master conference phone receives at least one network data packet through an Ethernet, obtains a real-time stream signal according to the at least one network data packet, plays the real-time stream signal after a delay, sends the real-time stream signal to the slave conference phone, periodically sends at least one synchronized broadcast packet to the slave conference phone.
    Type: Application
    Filed: October 9, 2019
    Publication date: May 7, 2020
    Inventor: Wenhui LIN
  • Patent number: 9630925
    Abstract: Disclosed are an Hsp90 inhibitor and a preparation method and use thereof. The Hsp90 inhibitor is 2-(4-(3-acetylcarnitineacyloxy)cyclohexylamino)-4-(1-(3,6,6-trimethyl-4-oxy-4,5,6,7-tetrahydroindazole))benzamide. The Hsp90 inhibitor has good water solubility and high bioavailability, and can effectively inhibit the proliferation of cancer cells, such as leukemia, cervical cancer, breast cancer, human laryngeal epithelial carcinoma, or malignant melanoma cells. It can also effectively inhibit the activity of herpes simplex virus. The maximal non-toxic concentration of the Hsp90 inhibitor on normal cells is a high, and the Hsp90 inhibitor only has specific inhibition effect on cancer cells.
    Type: Grant
    Filed: February 16, 2011
    Date of Patent: April 25, 2017
    Assignee: Jinan University
    Inventors: Yifei Wang, Guowen Xing, Huaiqiang Ju, Wenhui Lin, Chuiwen Qian, Min Xia, Xiaoping Zhou, Meiying Zhang
  • Publication number: 20150352048
    Abstract: The present invention relates to a compound solid preparation and the preparation method therefor and specifically relates to a valsartan-amlodipine compound solid preparation and the preparation method therefor. The valsartan-amlodipine compound solid preparation comprises valsartan particles and an amlodipine premix. The valsartan particles are prepared by preparing wet valsartan particles from a mixture obtained by mixing valsartan and a pharmaceutic adjuvant with an ethanol aqueous solution as a wetting agent and drying the wet valsartan particles. The amlodipine premix is prepared by mixing amlodipine and a pharmaceutic adjuvant. The valsartan-amlodipine compound solid preparation according to the present invention and the preparation method thereof can prevent the two main ingredients, amlodipine and valsartan, from interfering each other, and the preparation method is relatively simple and suitable for large-scale industrial production.
    Type: Application
    Filed: June 21, 2013
    Publication date: December 10, 2015
    Inventors: Wenhui LIN, Kepan GAO, Ling FU, Li YING, Chen WU, Haitao ZHAO
  • Publication number: 20130190509
    Abstract: Disclosed are an Hsp90 inhibitor and a preparation method and use thereof. The Hsp90 inhibitor is 2-(4-(3-acetylcarnitineacyloxy)cyclohexylamino)-4-(1-(3,6,6-trimethyl-4-oxy-4,5,6,7-tetrahydroindazole))benzamide. The Hsp90 inhibitor has good water solubility and high bioavailability, and can effectively inhibit the proliferation of cancer cells, such as leukemia, cervical cancer, breast cancer, human laryngeal epithelial carcinoma, or malignant melanoma cells. It can also effectively inhibit the activity of herpes simplex virus. The maximal non-toxic concentration of the Hsp90 inhibitor on normal cells is a high, and the Hsp90 inhibitor only has specific inhibition effect on cancer cells.
    Type: Application
    Filed: February 16, 2011
    Publication date: July 25, 2013
    Inventors: Yifei Wang, Guowen Xing, Huaiqiang Ju, Wenhui Lin, Chuiwen Qian, Min Xia, Xiaoping Zhou, Meiying Zhang